(Press-News.org) Digital solutions including remote monitoring can help chronic pain sufferers manage their pain and reduce the probability of misuse of prescription opioids.
For chronic pain sufferers an app may be just the tool they need to manage their pain. In a UHN-led study that used the app "Manage My Pain" enrolled patients saw clinically significant reductions in key areas that drive increased medical needs, potential abuse of prescription opioids and of course, pain.
Toronto (March 4, 2021) - For the first time, an app has been shown to reduce key symptoms of chronic pain. A UHN-led study evaluated the impact of Manage My Pain (MMP), a digital health solution developed by ManagingLife, on patients seen at the Iroquois Falls Family Health Team, and the Toronto Western and Toronto General Hospitals.
Published today in JMIR mHealth, a leading peer-reviewed journal focused on health and biomedical applications, the study showed patients who used the MMP app saw a clinically significant reduction in anxiety and pain catastrophizing, two key areas that drive increased medical needs and potential abuse of prescription opioid.
"Manage My Pain has helped our patients tell their story," says Dr. Hance Clarke, Director Pain Services, Medical Director of The Pain Research Unit, Toronto General Hospital, UHN. "As a result, this has empowered them to engage in discussions that enabled us to come up with patient-centered treatment plans to help manage their pain."
246 participants with chronic pain were enrolled in the study and more than 70 per cent of the group agreed to use the app along with their medication, psychological therapy, and physiotherapy, the other 30 per cent were the control group. The app allowed them to track their pain, create reports that facilitated better communication with their care providers, and through a virtual portal, give clinicians the ability to remotely monitor their patients and use advanced analytics to spot any negative trends weeks and months in advance.
"Prior to Manage My Pain, our clinic was dependent on paper-based questionnaires to understand a patient's pain experience and response to treatment," says Dr. Anuj Bhatia, Site Director, Anesthesia - Interventional Pain Service, Toronto Western Hospital, UHN. "The app allows us to capture even more information than we had previously, while doing so digitally and remotely. The app also allowed us to study trends in intensity of pain and its impact on the patients' lives."
Patients were prompted daily to record their reflections in the app. In less than a minute, they could input the activities they were able to accomplish and rate the pain they felt. In return, they received charts and graphs that highlighted patterns and trends that could increase their self-awareness, and provide insight into triggers and interventions.
For the rural patients involved in this study, the benefits of MMP were remarkably clear from the beginning. Lacking a speciality pain centre, patients in Iroquois Falls must rely on their primary caregivers and the app made the communication between the patient-clinician easier and more productive.
"Chronic pain isn't like a broken arm," says Dr. Auri Bruno-Petrina, rural Physician, Iroquois Falls. "It can be invisible to the naked eye, so people who suffer from it can find it very frustrating to explain how they are feeling and how much it is impacting their lives. This app strengthened my ability to help my patients because we had more nuanced data and we could really dig into the details."
For both rural and urban patients suffering from chronic pain, the use of MMP encouraged tracking and reflecting, both of which are important components of most self-management programs. The ease of adoption also presents a positive opportunity for engaging with patients during significant challenges like the one presented by the COVID-19 pandemic.
"The COVID-19 pandemic has shown us how essential it is for patients to have a role in managing healthcare conditions," says Dr. Clarke. "Digital tools like Manage My Pain are a great way to empower self-management in patients, which is one of the hallmarks of successful clinical care."
INFORMATION:
This study was funded by the Health technologies Fund (HTF), a program of the government of Ontario's Office of the Chief Health Innovation Strategist (OCHIS), administered by the Ontario Centres for Excellence (OCE).
Contact for Media:
Rosa Kim, Senior Public Affairs Advisor
Toronto General Hospital and Peter Munk Cardiac Centre
Phone: 647 669 8416
Email: rosa.kim@uhn.ca
About University Health Network
University Health Network consists of Toronto General, recently ranked the #4 Hospital in the World according to Newsweek Magazine, and Toronto Western Hospital, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and the Michener Institute of Education at UHN. The scope of research and complexity of cases at University Health Network has made it a national and international source of discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto. http://www.uhn.ca
The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them. Scientists from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have now shown that SARS-CoV-2 can make itself unrecognizable to the immune response by T-killer cells through mutations. The findings of the research groups of Andreas Bergthaler, Judith Aberle and Johannes Huppa provide important clues for the further development of vaccines and were published in the journal Science ...
A recent study outlines a range of privacy concerns related to the programs that users interact with when using Amazon's voice-activated assistant, Alexa. Issues range from misleading privacy policies to the ability of third-parties to change the code of their programs after receiving Amazon approval.
"When people use Alexa to play games or seek information, they often think they're interacting only with Amazon," says Anupam Das, co-author of the paper and an assistant professor of computer science at North Carolina State University. "But a lot of the applications they are interacting with were created by third parties, and we've identified several flaws in the current vetting process that could allow those third parties to gain access to users' personal or private ...
Cervical cancer is a serious global health threat which kills more than 300,000 women every year. It's a disease that disproportionately affects women in low- and middle-income countries in equatorial Africa, Latin America and Southeast Asia, yet it is a preventable disease and decades of research have produced the tools needed to eliminate it.
Recognizing this urgent public health issue, the editorial team of Preventive Medicine, led by Editor-in-Chief Dr. Eduardo Franco, Director, Division of Cancer Epidemiology and Chair, Gerald Bronfman Department ...
Researchers in Japan have developed the first wearable devices to precisely monitor jaundice, a yellowing of the skin caused by elevated bilirubin levels in the blood that can cause severe medical conditions in newborns. Jaundice can be treated easily by irradiating the infant with blue light that breaks bilirubin down to be excreted through urine. The treatment itself, however, can disrupt bonding time, cause dehydration and increase the risks of allergic diseases. Neonatal jaundice is one of the leading causes of death and brain damage in infants in low- and middle-income countries.
To address the tricky balance ...
On Earth, plate tectonics is not only responsible for the rise of mountains and earthquakes. It is also an essential part of the cycle that brings material from the planet's interior to the surface and the atmosphere, and then transports it back beneath the Earth's crust. Tectonics thus has a vital influence on the conditions that ultimately make Earth habitable.
Until now, researchers have found no evidence of global tectonic activity on planets outside our solar system. A team of researchers led by Tobias Meier from the Center for Space and Habitability (CSH) at the University of Bern and with the participation of ETH Zurich, the University of Oxford and the National Center of Competence in Research NCCR PlanetS has now found evidence of the flow patterns inside ...
Female gannets travel further than male gannets to find fish for their chicks in some years but not others, new research shows.
Scientists tracked breeding gannets from Grassholm Island in Wales over 11 years with tiny GPS devices and by measuring isotopic signatures in their blood.
Male gannets flew an average of 220km to forage for their chicks, while females averaged 260km. Some birds travelled 1,000km on a single trip.
The scientists also found that the two sexes selected different habitats and foraged at different times of day, but some years ...
COLUMBUS, Ohio - Putting a price on producing carbon is the cheapest, most efficient policy change legislators can make to reduce emissions that cause climate change, new research suggests.
The case study, published recently in the journal Current Sustainable/Renewable Energy Reports, analyzed the costs and effects that a variety of policy changes would have on reducing carbon dioxide emissions from electricity generation in Texas and found that adding a price, based on the cost of climate change, to carbon was the most effective.
"If the goal is reducing carbon dioxide in the atmosphere, what we found is that putting a price on carbon and then letting suppliers and consumers make their ...
In order to show the clinical relevance of a difference between two treatment alternatives, in recent years, the manufacturer dossiers submitted in early benefit assessments of new drugs have increasingly contained responder analyses for patient-relevant outcomes. In such analyses, it is investigated whether the proportion of patients experiencing a noticeable change in the respective outcome differs between the two treatment groups in a study. This involves information on health-related quality of life or on individual symptoms such as pain or itching, which patients recorded with the help of scales in questionnaires.
But what difference makes a change relevant for the individual? That is, at what threshold can a response to an intervention be derived for ...
A deep sequencing study of 747 SARS-CoV-2 virus isolates has revealed mutant peptides derived from the virus that cannot effectively bind to critical proteins on the surface of infected cells and, in turn, hamper activation of CD8+ killer T cells that recognize and destroy these infected cells. These peptides, the authors say, represent one way the coronavirus subverts killer T cell responses and stymies immunity in the host. Their results may be of particular importance for SARS-CoV-2 subunit vaccines, such as the RNA vaccines currently in use, which induce responses against a limited number of viral ...
There are no therapeutics available that have been developed for COVID-19 treatment. Repurposing of already available medication for COVID-19 therapy is an attractive option to shorten the road to treatment development. The drug Camostat could be suitable. Camostat exerts antiviral activity by blocking the protease TMPRSS2, which is used by SARS-CoV-2 for entry into cells. However, it was previously unknown whether SARS-CoV-2 can use TMPRSS2-related proteases for cell entry and whether these proteases can be blocked by Camostat. Moreover, it was unclear whether metabolization of Camostat interferes with antiviral activity. An international team of researchers around Markus Hoffmann and Stefan Pöhlmann ...
